Skip to main content
Log in

Fibrin degradation product D-dimer in the diagnosis of pulmonary embolism

  • Originals
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

Summary

The study objective was to determine the specificity and sensitivity of plasma concentrations of D-dimer, a fibrin degradation product, as a marker for ongoing thrombotic and thrombolytic events in pulmonary embolism. A prospective study was performed in 74 patients with suspected pulmonary embolism who appeared in the emergency room with dyspnea and/or chest pain.

The presence of pulmonary embolism was established by positive findings either in pulmonary angiography or lung scan. D-dimer concentrations were determined in all patients. In 11 patients with positive pulmonary angiography, D-dimer concentrations were monitored for 6–12 days.

D-dimer concentrations were determined by a quantitative enzyme-linked immunoassay. Plasma probes of 26 patients (16 with/10 without positive pulmonary angiography) were reassayed with a semiquantitative latex agglutination assay. D-dimer levels were significantly higher in patients with pulmonary embolism (>1000 ng/mL in 41 out of 43) than in those without (<1000 ng/mL in all 21 patients) (p<0.01).

The sensitivity and specificity for the ELISA were found to be 95% and 100%, respectively, for establishing the diagnosis of pulmonary embolism. In the latex assay the values were 81% and 60%, respectively.

It is concluded that in patients with dyspnea and/or chest pain, determination of D-dimer in plasma by ELISA adds a valuable tool to the noninvasive diagnostic procedure for pulmonary embolism. From the time-course of D-dimer values we conclude that this assay might be valuable up to at least 6 days after symptom onset. The assay, however, is unreliable in malignancies or after surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

apPE:

angiographically proven pulmonary embolism

hpPE:

highly probable pulmonary embolism

imPE:

highly improbable pulmonary embolism

rPE:

pulmonary embolism ruled out

pPE:

possible pulmonary embolism

References

  1. Alderson PO, Biello DR, Sachariah KG, Siegel BA (1981) Scintigraphic detection of pulmonary embolism in patients with obstructive pulmonary disease. Radiology 138:661–666

    Google Scholar 

  2. Barritt DW, Jordan SC (1960) Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet I:1309–1312

    Google Scholar 

  3. Bounameaux H, Cirafici P, De Moerloose P, Schneider PA, Slosman D, Reber G, Unger PF (1991) Measurement of D-dimer in plasma as diagnostic aid in suspected pulmonary embolism. Lancet 337:196–200

    Google Scholar 

  4. Branch WT, McNeil BJ (1983) Analysis of the differential diagnosis and assessment of pleuritic chest pain in young adults. Am J Med 75:671–679

    Google Scholar 

  5. Bridey F, Phlipotteau C, Dreyfus M, Simonneau G (1989) Plasma D-dimer and pulmonary embolism. Lancet 1:791–792

    Google Scholar 

  6. Cheely R, McCartney WH, Perry JR, Delany DJ, Bustad L, Wynia VH, Griggs TR (1981) The role of noninvasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism. Am J Med 70:17–22

    Google Scholar 

  7. Coon WW (1976) The spectrum of pulmonary embolism. Arch Surg 111:398–402

    Google Scholar 

  8. Dalen JE, Alpert JS (1975) Natural history of pulmonary embolism. Prog Cardiovasc Dis 17:259–270

    Google Scholar 

  9. Elms MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Mascí PP, Whithaker AN (1986) Rapid detection of cross-linked fibrin degradation products in plasma using monoclonal antibody-coated latex particles. Am J Clin Pathol 85:360–364

    Google Scholar 

  10. Fischer KC, McNeil B (1979) The indeterminate lung scan: its characteristics and its association with pulmonary embolism. Eur J Nucl Med 4:49–53

    Google Scholar 

  11. Franke M, Hafter R, von Hugo R, Röbl M, Graeff H (1986) Ein Test zum Nachweis von Fibrin im Plasma. Geburtshilfe Frauenheilkd 46:105–109

    Google Scholar 

  12. Gaffney PJ, Creighton LJ, Callus M, Thorpe R (1988) Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II: Evaluation in a variety of clinical conditions. Br J Haematol 68:91–96

    Google Scholar 

  13. Goldhaber SZ, Vaughan DE, Tumeh SS, Loscalzo J (1988) Utility of cross-linked fibrin degradation products in the diagnosis of pulmonary embolism. Am Heart J 116:505–508

    Google Scholar 

  14. Hull RD, Hirsh J, Carter CJ, Jay RM, Dodd PE, Ockelford PA, Coates G, Gill GJ, Turpie AG, Doyle DJ, Buller HR, Raskob GE (1983) Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Int Med 98:891–899

    Google Scholar 

  15. Hunt FA, Rylatt DB, Hart R-A, Bundesen PG (1985) Serum crosslinked fibrin (XDP) and fibrinogen/fibrin degradation products (FDP) in disorders associated with activation of the coagulation of fibrinolytic systems. Br J Haematol 60:715–722

    Google Scholar 

  16. Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE (1987) Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery diseases. N Engl J Med 317:1361–1365

    Google Scholar 

  17. Müller-Berghaus G, Scheefers-Borchel U, Selmayr E, Henschen A (1986) Fibrinogen and its derivatives. Elsevier, Amsterdam New York

    Google Scholar 

  18. Murray HW, Ellis GC, Blumenthal DS, Sos TA (1979) Fever and pulmonary thromboembolism. Am J Med 67:232–235

    Google Scholar 

  19. Reilly BM (1984) Practical strategies in outpatient medicine. Saunders, Philadelphia

    Google Scholar 

  20. Stötzer K-E, Amiral J, Spanuth E (1988) Neue Methoden zur spezifischen Bestimmung von Fibrinspaltprodukten (D-Dimere). Lab Med 12:51–55

    Google Scholar 

  21. Szucs MM, Brooks HL, Grossman W, Banas JS, Meister SG, Dexter L, Dalen JE (1971) Diagnostic sensitivity of laboratory findings in acute pulmonary embolism. Ann Intern Med 74:161–166

    Google Scholar 

  22. The PIOPED Investigators (1990) Value of the ventilation/ perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA 263:2753–2759

    Google Scholar 

  23. Van Hulsteijn H, Bertina R, Briet E (1982) A one-year follow-up study of plasma fibrinopeptide A and beta-thromboglobulin after deep vein thrombosis and pulmonary embolism. Thromb Res 27:225–229

    Google Scholar 

  24. Whitaker AN, Elms MJ, Masci PP, Bundesen PG, Rylatt DB, Webber AJ, Bunce IH (1984) Measurement of cross linked fibrin derivatives in plasma: an immunoassay using monoclonal antibodies. J Clin Pathol 37:882–887

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lichey, J., Reschofski, I., Dissmann, T. et al. Fibrin degradation product D-dimer in the diagnosis of pulmonary embolism. Klin Wochenschr 69, 522–526 (1991). https://doi.org/10.1007/BF01649289

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01649289

Key words

Navigation